ASST vs FHI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

ASST

46.3
AI Score
VS
FHI Wins

FHI

59.6
AI Score

Investment Advisor Scores

ASST

46score
Recommendation
HOLD

FHI

60score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ASST FHI Winner
Forward P/E 5.5006 9.9206 ASST
PEG Ratio 0 1.3978 Tie
Revenue Growth 94.6% 18.3% ASST
Earnings Growth 0.0% 19.3% FHI
Tradestie Score 46.3/100 59.6/100 FHI
Profit Margin 0.0% 21.3% FHI
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY FHI

Relative Price Performance (Last 90 Days)

ASST 1M: +0.1% · 3M: +152.7% FHI 1M: +0.2% · 3M: -0.4%

Current Technical Phase

ASST

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (34.0% over 20 days), RSI 56

RSI (14): 56.2 · Price: $29.03

FHI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.6 · Price: $57.67

Fundamentals Snapshot

Metric ASST FHI
Market Cap — —
Forward P/E -30.2 9.7
Trailing P/E — 10.4
Revenue (TTM) — —
Revenue Growth 0.9% 0.2%
Gross Margin -6.0% 0.7%
Operating Margin -84.8% 0.3%
EPS -204.80 5.37
Dividend Yield — 0.03%

Frequently Asked Questions

Based on our detailed analysis, FHI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.